RAD 3.85% 2.7¢ radiopharm theranostics limited

News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN, page-19

  1. 1,607 Posts.
    lightbulb Created with Sketch. 523
    Heaps of posters seem to share your sentiment.

    I've watched a few ASX listed biotechs duel list on the NASDAQ and if anything they started to get pummeled even worse.

    And a couple of NASDAQ only listed biotechs I follow have share prices a tiny fraction of what they were a year or two ago.

    Even the US biotech ETFs seem to underperform the main indices.
 
watchlist Created with Sketch. Add RAD (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.001(3.85%)
Mkt cap ! $58.66M
Open High Low Value Volume
2.8¢ 2.9¢ 2.7¢ $274.3K 10.02M

Buyers (Bids)

No. Vol. Price($)
3 416231 2.6¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 888375 4
View Market Depth
Last trade - 15.54pm 19/11/2024 (20 minute delay) ?
RAD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.